For the Inventor, By the Inventor

Enter assignee name

Wilmington, DE, United States of America

Dupont Pharmaceuticals, Inc.

USPTO Granted Patents = 15

Trademarks = 1

Forward Citations = 224

Loading Chart...

Loading Chart...

32 inventors (with patents filed for the assignee):

Robert J Chorvat (4 out of 48 patents)

James Peter Beck (4 out of 13 patents)

Paul Joseph Gilligan (4 out of 47 patents)

4. Rajagopal Bakthavatchalam (2 out of 40 patents)

5. Richard Eric Olson (2 out of 108 patents)

6. Argyrios Georgios Arvanitis (2 out of 13 patents)

7. Douglas G Batt (1 out of 54 patents)

8. Michael J Orwat (1 out of 43 patents)

9. John Wityak (1 out of 49 patents)

10. Soo Sung Ko (1 out of 41 patents)

11. Zhe Wang (1 out of 74 patents)

12. Carl Henry Behrens (1 out of 13 patents)

13. Matthew A Curry (1 out of 6 patents)

14. Parthasarathi Rajagopalan (1 out of 13 patents)

15. Ronald L Magolda (1 out of 14 patents)

15 patents: Sort by Forward Citations

1. 6544417 - Low binding liquid retaining and filtering device (2003-04-08),

2. 6218386 - A1-(3-aminoindazol-5-yl)-3 butyl-cyclic urea useful as a HIV protease inhibitor (2001-04-17),

3. 6136809 - Azolo triazines and pyrimidines (2000-10-24),

4. 6130231 - Integrin receptor antagonists (2000-10-10),

5. 6124463 - Benzimidazoles as corticotropin release factor antagonists (2000-09-26),

6. 6124302 - 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones useful as HIV reverse (2000-09-25),

7. 6124300 - Aryloxy- and arylthio- fused pyridines and pyrimidines and derivatives (2000-09-26),

8. 6110910 - Carbocyclic heterocyclic fused-ring quinolinecarboxylic acids useful as (2000-08-29),

9. 6107300 - Arylamino fused pyrimidines (2000-08-22),

10. 6107294 - Thiazolo[4,5-d]pyrimidines and pyridines as corticotropin releasing (2000-08-22),

11. 6060491 - 6-membered aromatics as factor Xa inhibitors (2000-05-09),

12. 6060478 - Azolo triazines and pyrimidines (2000-05-09),

13. 6056958 - Method of treatment of arterial and venous thromboembolic disorders (2000-05-02),

14. 6054597 - Processes and intermediates for the preparation of cyclic urea HIV (2000-04-25),

15. 6049019 - Process for the preparation of cyclopropylacetylene (2000-04-11),

Dupont Pharmaceuticals, Inc. is a leading pharmaceutical company focused on developing innovative medicines to improve the lives of patients. With a strong commitment to research and development, Dupont Pharmaceuticals strives to address unmet medical needs and advance healthcare for individuals worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

15 Patents

#245 in Wilmington, DE

#323 in Delaware

#20,432 in US

#38,721 in the World

Wilmington, DE, United States of America

Dupont Pharmaceuticals, Inc.

Forward Citations = 224

32 inventors:

Robert J Chorvat (4 out of 48 patents)

James Peter Beck (4 out of 13 patents)

Paul Joseph Gilligan (4 out of 47 patents)

4. Rajagopal Bakthavatchalam (2 out of 40 patents)

5. Richard Eric Olson (2 out of 108 patents)

Please report any incorrect information to support@idiyas.com

Loading…